Want to see HK:0656 full AI Analyst Report?
0656 Stock Chart & Stats
HK$4.32
-HK$0.02(-0.46%)
At close: 4:00 PM EDT
HK$4.32
-HK$0.02(-0.46%)
Day’s Range― - ―
52-Week RangeHK$3.42 - HK$6.81
Previous CloseN/A
Volume5.99M
Average Volume (3M)7.09M
Market Cap
HK$38.87B
Enterprise ValueHK$274.30K
Total Cash (Recent Filing)HK$97.43B
Total Debt (Recent Filing)HK$250.68B
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.42%
Share Statistics
EPS (TTM)-2.88
Shares Outstanding8,135,322,000
10 Day Avg. Volume5,394,621
30 Day Avg. Volume7,085,908
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.34
Price to Sales (P/S)0.18
P/FCF Ratio2.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.00Price Target Upside15.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.31
Revenue Forecast (FY)HK$192.99B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow GenerationSustained positive operating cash flow across 2022–2025 and rising free cash flow in 2024–2025 signal improving internal liquidity. Over the medium term this provides a durable source to fund operations, undertake selective deleveraging or invest in core platforms without relying solely on external financing.
Diversified Consumer-facing PortfolioA diversified conglomerate across health, tourism/leisure and financial services reduces single-sector exposure and can smooth cash flows across cycles. This structural diversification supports resilience: weaknesses in one segment may be offset by stability or growth in others over the 2–6 month horizon and beyond.
Improved Operating MarginsMaterial operating margin improvement in 2025 indicates stronger unit economics or cost discipline at the operating level. If sustained, higher gross and EBIT margins enhance cash conversion and create scope to absorb financing or non-operating charges, improving long-term earnings quality and operational resilience.
Bears Say
High LeverageA debt-to-equity ratio near 2.4x materially constrains financial flexibility and raises refinancing and interest-rate sensitivity. Over the medium term high leverage limits capacity for acquisitions or capital spending, increases vulnerability to credit market shifts, and can force asset sales or cost cutting if cash flow deteriorates.
Declining Revenue TrendConsecutive revenue declines point to weakening demand or market share pressure across businesses. Persistent top-line contraction reduces scale benefits and margin headroom, making it harder to cover fixed costs and service debt; this structural trend threatens medium-term recovery unless reversed by sustained growth initiatives.
Material Net Losses And Weak ROELarge net losses and negative ROE signal earnings power is currently insufficient to justify equity capital. Over a multi-month horizon, sustained losses erode equity, constrain dividend capacity, and may necessitate asset disposals or capital injections to restore balance-sheet health, especially given the group's high leverage.
Fosun International News
0656 FAQ
What was Fosun International Limited’s price range in the past 12 months?
Fosun International Limited lowest stock price was HK$3.42 and its highest was HK$6.81 in the past 12 months.
What is Fosun International Limited’s market cap?
Fosun International Limited’s market cap is HK$38.87B.
When is Fosun International Limited’s upcoming earnings report date?
Fosun International Limited’s upcoming earnings report date is Sep 02, 2026 which is in 32 days.
How were Fosun International Limited’s earnings last quarter?
Fosun International Limited released its earnings results on Mar 30, 2026. The company reported -HK$3.239 earnings per share for the quarter, missing the consensus estimate of HK$0.105 by -HK$3.344.
Is Fosun International Limited overvalued?
According to Wall Street analysts Fosun International Limited’s price is currently Undervalued.
Does Fosun International Limited pay dividends?
Fosun International Limited pays a Annually dividend of HK$0.02 which represents an annual dividend yield of 0.42%. See more information on Fosun International Limited dividends here
What is Fosun International Limited’s EPS estimate?
Fosun International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fosun International Limited have?
Fosun International Limited has 8,135,322,000 shares outstanding.
What happened to Fosun International Limited’s price movement after its last earnings report?
Fosun International Limited reported an EPS of -HK$3.239 in its last earnings report, missing expectations of HK$0.105. Following the earnings report the stock price went down -2.179%.
Which hedge fund is a major shareholder of Fosun International Limited?
Currently, no hedge funds are holding shares in HK:0656
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Fosun International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$5.00 (15.74% Upside)
HK$5.00 (15.74% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.19%
12-Months-Change
Fundamentals
Return on Equity
0.42%
Trailing 12-Months
Asset Growth
-6.08%
Trailing 12-Months
Company Description
Fosun International Limited
Fosun International Limited operates as a global conglomerate, concentrating its diverse activities within the health, lifestyle, wealth management, and advanced manufacturing sectors. Its reach extends across Mainland China, Portugal, and various international territories. The company's comprehensive business model is primarily organized into five distinct segments: Health: This division is dedicated to the research, development, production, distribution, and commercialization of pharmaceuticals, biopharmaceuticals, and other health-related products, complemented by medical and health management services. Happiness: Focused on consumer experiences, this segment manages and invests in businesses related to tourism, leisure, fashion, and broader lifestyle industries. Insurance: Encompasses both the operation of insurance services and strategic investments within the global insurance market. Asset Management: This segment specializes in asset management services and various market investment activities. Intelligent Manufacturing: Involves both direct operations and investment in advanced manufacturing processes, including the production of iron and steel ore. Furthermore, Fosun International engages in capital investment and management, real estate development, retail, and reinsurance. Its extensive operations also include the manufacturing and sale of iron and steel products, provision of banking and financial services, medical consultation, and digital solution delivery. Founded in 1992 and headquartered in Shanghai, China, Fosun International Limited is a subsidiary of Fosun Holdings Limited.
0656 Company Deck
0656 Earnings Call
Q4 2026
0:00 / 0:00
0656 Stock 12 Month Forecast
Average Price Target
HK$5.00
▲(15.74% Upside)
Technical Analysis
CK Hutchison Holdings
―
CITIC
―
Guoco Group
―
Shanghai Industrial Holdings
―
Swire Pacific
―